Breast imaging developer Dexela has begun commercial shipments of its DexTop breast imaging workstation.
DexTop supports full-field digital mammography (FFDM) images as well as breast tomosynthesis, according to the London-based firm. It employs a 64-bit computing platform and graphics hardware and a modular, Web services-based architecture, Dexela said. DexTop has received both the European CE Mark and U.S. Food and Drug Administration (FDA) 510(k) clearance.
In other Dexela news, the company has named Peter Denyer as director and nonexecutive chairman. Denyer founded and built CMOS imager chip developer Vision Group and will replace Mike Brady as chairman. Brady will remain on the board and continue to serve as chairman of Dexela's scientific advisory board, Dexela said.
Dexela also said it has raised 2.6 million pounds ($5.2 million U.S.) through a round of fundraising, which included Close Ventures and London Technology Fund as main investors. Proceeds will be used to support ongoing development and commercialization of Dexela's imaging technology, according to the company.
Related Reading
Dexela awarded development grant, November 28, 2007
British firm Dexela focuses on 3D mammography workstation, October 27, 2006
Dexela scores funding, May 19, 2006
Copyright © 2008 AuntMinnie.com
